Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2,977 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Sitagliptin: a novel drug for the treatment of type 2 diabetes.
Choy M, Lam S. Choy M, et al. Cardiol Rev. 2007 Sep-Oct;15(5):264-71. doi: 10.1097/CRD.0b013e318123f771. Cardiol Rev. 2007. PMID: 17700385 Review.
Impact of an interdisciplinary team on drug therapy outcomes in a geriatric clinic.
Lam S, Ruby CM. Lam S, et al. Am J Health Syst Pharm. 2005 Mar 15;62(6):626-9. doi: 10.1093/ajhp/62.6.626. Am J Health Syst Pharm. 2005. PMID: 15757885 No abstract available.
Exenatide: a novel incretin mimetic agent for treating type 2 diabetes mellitus.
Lam S, See S. Lam S, et al. Cardiol Rev. 2006 Jul-Aug;14(4):205-11. doi: 10.1097/01.crd.0000223655.16253.e4. Cardiol Rev. 2006. PMID: 16788334 Review.
Exenatide was approved by the U.S. Food and Drug Administration for the treatment of type 2 diabetes in conjunction with metformin and/or sulfonylurea. ...
Exenatide was approved by the U.S. Food and Drug Administration for the treatment of type 2 diabetes in conjunction with metformin an …
Azilsartan: a newly approved angiotensin II receptor blocker.
Lam S. Lam S. Cardiol Rev. 2011 Nov-Dec;19(6):300-4. doi: 10.1097/CRD.0b013e31822e9ba3. Cardiol Rev. 2011. PMID: 21983318 Review.
Emerging therapies for the treatment of Helicobacter pylori infections.
Jodlowski TZ, Lam S, Ashby CR Jr. Jodlowski TZ, et al. Ann Pharmacother. 2008 Nov;42(11):1621-39. doi: 10.1345/aph.1L234. Epub 2008 Oct 9. Ann Pharmacother. 2008. PMID: 18845620
Strontium ranelate for the management of osteoporosis.
Lam S, Zouzias K. Lam S, et al. Consult Pharm. 2008 Jul;23(7):531-7. doi: 10.4140/tcp.n.2008.531. Consult Pharm. 2008. PMID: 18764671
Interferon-beta1b for the treatment of multiple sclerosis.
Lam S, Wang S, Gottesman M. Lam S, et al. Expert Opin Drug Metab Toxicol. 2008 Aug;4(8):1111-7. doi: 10.1517/17425255.4.8.1111. Expert Opin Drug Metab Toxicol. 2008. PMID: 18680445 Review.
Aliskiren: an oral renin inhibitor for the treatment of hypertension.
Lam S, Choy M. Lam S, et al. Cardiol Rev. 2007 Nov-Dec;15(6):316-23. doi: 10.1097/CRD.0b013e31814852a4. Cardiol Rev. 2007. PMID: 18090068 Review.
Pharmacologic management of overactive bladder.
Lam S, Hilas O. Lam S, et al. Clin Interv Aging. 2007;2(3):337-45. Clin Interv Aging. 2007. PMID: 18044184 Free PMC article. Review.
2,977 results
Jump to page
Feedback